PPARD, with its direct target genes ADRP and ANGPTL4, might serve as a novel biomarker for CAD, particularly when combined with risk factors [9,10], since the positive association between PPARD polymorphism rs2016520 and CAD had previously been reported [11]. This evidence concerns the gene ANGPTL4 and coronary artery disorder.